Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms Underlying Metabolic Syndrome in Obesity

NCT00579813 is registered in ClinicalTrials.gov with Philip Kern as lead sponsor.

NCT NCT00579813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00579813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms Underlying Metabolic Syndrome in Obesity
Lead sponsor
Philip Kern
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2005
Completion date
January 31, 2011
Enrollment
70 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome, prediabetes